» Articles » PMID: 17924778

Sex Steroid Hormones, Stress Response, and Drug Craving in Cocaine-dependent Women: Implications for Relapse Susceptibility

Overview
Specialty Pharmacology
Date 2007 Oct 11
PMID 17924778
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Cocaine dependence is associated with an enhanced sensitivity to stress and drug craving. Increases in stress-induced craving and hypothalamic-pituitary-adrenal reactivity are also predictive of cocaine relapse outcomes. More important, sex differences in these responses have also been reported. To further understand the basis of the sex differences, the authors examined the influence of sex steroid hormones on subjective and physiological stress responses and drug craving in cocaine-dependent women. Women who had low progesterone levels (n=5) were compared with those with high progesterone levels (n=5) and with those with moderate levels of estradiol and progesterone (n=9) in their responses during exposure to stress, cocaine cues, and neutral imagery conditions. The high progesterone group showed significantly lower stress-induced and drug cue-induced cocaine craving ( p<.05) and reduced drug cue-induced anxiety levels ( p<.08) and lower drug cue-induced systolic and diastolic blood pressure levels compared with the low progesterone group. These data suggest that there are significant effects of sex steroid hormones on stress and drug cue-induced cocaine craving, anxiety, and cardiovascular responses. In particular, high progesterone during the midluteal phase of the cycle was associated with decreased stress-induced and drug cue-induced craving and decreased cue-induced anxiety and blood pressure responses. These findings are consistent with previous preclinical and clinical studies of progesterone's effects on the behavioral responses to cocaine and warrant further research to examine the effects of progesterone on stress-induced cocaine craving, stress arousal, and cocaine relapse susceptibility in women.

Citing Articles

Gender-related differences in addiction: a review of human studies.

Zakiniaeiz Y, Potenza M Curr Opin Behav Sci. 2025; 23:171-175.

PMID: 39896826 PMC: 11784943. DOI: 10.1016/j.cobeha.2018.08.004.


Prevention of postpartum methamphetamine use with micronized progesterone trial (PROMPT): A pilot randomized controlled trial protocol.

Smid M, Seliski N, Charles J, Castro S, Humiston G, Cash E Contemp Clin Trials Commun. 2024; 41:101359.

PMID: 39308801 PMC: 11415636. DOI: 10.1016/j.conctc.2024.101359.


Substance use patterns, quantities, and associated risk factors in women with polysubstance misuse.

Fogelman N, Tate M, Wemm S, Sullivan L, Hart R, Vacey E Addict Biol. 2024; 29(4).

PMID: 38619491 PMC: 11017971. DOI: 10.1111/adb.13390.


Mifepristone decreases nicotine intake in dependent and non-dependent adult rats.

Chellian R, Behnood-Rod A, Bruijnzeel A J Psychopharmacol. 2024; 38(3):280-296.

PMID: 38332661 PMC: 11061865. DOI: 10.1177/02698811241230255.


Progesterone Attenuates the Stress Response in Individuals with Alcohol Dependence and Post-Traumatic Stress Disorder - A Pilot Study.

Ralevski E, Newcomb J, Pisani E, DeNegre D, Peltier M, Jane J J Dual Diagn. 2023; 20(1):39-51.

PMID: 38147491 PMC: 11214330. DOI: 10.1080/15504263.2023.2294989.